Location of Repository

Do the Changes in the Serum Levels of IL-2, IL-4, TNFα, and IL-6 Reflect the Inflammatory Activity in the Patients with Post-ERCP Pancreatitis?

By Guldem Kilciler, Ugur Musabak, Sait Bagci, Zeki Yesilova, Ahmet Tuzun, Ahmet Uygun, Mustafa Gulsen, Sema Oren, Cagatay Oktenli and Necmettin Karaeren


Background. Acute pancreatitis is the major complication of endoscopic retrograde cholangiopancreatography (ERCP) procedure and there are some reports showing cytokine changes in ERCP-induced pancreatits. Goals. To investigate the association between early changes (within 24 hours) in the serum interleukin (IL)-2, IL-4, tumor necrosis factor (TNF)α, and IL-6 levels and the development of post-ERCP pancreatitis. Study. Forty five consecutive patients who underwent therapeutic ERCP and 10 patients with acute pancreatitis without ERCP were enrolled to the study. Serum concentrations of IL-2, IL-4, TNFα, and IL-6 were determined immediately before, 12 hours and 24 hours after ERCP. Results. Seven of the 45 patients (15.5%) developed post-ERCP pancreatitis. The levels of IL-4 at 24 hours after ERCP were significantly lower in the patients with post-ERCP pancreatitis than in those without pancreatitis, while TNFα levels at 12 hours after ERCP were higher in the complicated group than those of the uncomplicated group. The ratios of TNFα/IL-4 at 12 and 24 hours after ERCP were found significantly higher in the patients with post-ERCP pancreatitis than in those without pancreatitis. IL-6 in the complicated patients was found significantly increased at 24 hours after ERCP. Conclusions. The enhancement of serum TNFα and IL-6 levels in the patients with ERCP-induced pancreatitis reflects the inflammatory activity. Additionally, these cytokines together with IL-4 can be used in clinical laboratory monitoring of ERCP

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:2486352
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis,
    2. (1986). a n dR .L .C o ffman, “Two types of murine helper T cell clone. I.Definitionaccordingtoprofilesoflymphokineactivitiesand secreted proteins,”
    3. (2001). Complications of diagnostic and therapeutic ERCP: a prospective multicenter study,”
    4. (2003). Cytokines,” in Cellular and Molecular
    5. (1998). Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis,”
    6. (2003). Early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography,”
    7. (1996). Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes,”
    8. (1976). G.Skude,L.Wehlin,T.Maruyana,andJ.Ariyama,“Hyperamylasaemia after duodenoscopy and retrograde cholangiopancreatography,”
    9. (2003). Immunity to microbes,” in Cellular and Molecular
    10. (2000). Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications,”
    11. (1998). Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist,”
    12. (2001). New serum markers for the detection of severe acute pancreatitis in humans,”
    13. (2001). Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis,”
    14. (2007). Pancreatits after endoscopic retrograde cholangio-pancreatography,”
    15. (1997). Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis,”
    16. (2001). reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography,”
    17. (2006). Risk factors for post-ERCP pancreatitis: a prospective multicenter study,”
    18. (1999). Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis,”
    19. (2001). Serum lipase, C-reactive protein, and interleukin-6 levels in ERCP-induced pancreatitis,”
    20. (2006). Serum matrix metalloproteinase 9 as a marker for the assessment of severe acute pancreatitis,”
    21. (1999). Simultaneous serum assays of lipase and interleukin-6 for early diagnosis and prognosis of acute pancreatitis,”
    22. (2006). Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases,” Reproductive Toxicology,
    23. (2002). What are the predictors of post-ERCP pancreatitis, and how useful are they?”
    24. (2002). Why the incidence of post-ERCP pancreatitis varies considerably? Factors affecting the diagnosis and the incidence of this complication,”

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.